Cargando…

Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model

BACKGROUND: Delay in fracture healing or non-union can be devastating complication. Recent studies have reported that teriparatide (TP) demonstrated effectively on callus formation and mechanical strength and zoledronate (ZA) increased the callus size and resistance at the fracture site in rat fract...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsubouchi, Yuta, Ikeda, Shinichi, Kataoka, Masashi, Tsumura, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202815/
https://www.ncbi.nlm.nih.gov/pubmed/30359257
http://dx.doi.org/10.1186/s13018-018-0917-8
_version_ 1783365760593166336
author Tsubouchi, Yuta
Ikeda, Shinichi
Kataoka, Masashi
Tsumura, Hiroshi
author_facet Tsubouchi, Yuta
Ikeda, Shinichi
Kataoka, Masashi
Tsumura, Hiroshi
author_sort Tsubouchi, Yuta
collection PubMed
description BACKGROUND: Delay in fracture healing or non-union can be devastating complication. Recent studies have reported that teriparatide (TP) demonstrated effectively on callus formation and mechanical strength and zoledronate (ZA) increased the callus size and resistance at the fracture site in rat fracture model. In this study, the effects of combination therapy with low dose TP and ZA on fracture healing was evaluated. METHODS: From 1 week post-operation, TP (5 times a week administration) and ZA (0.1 mg/kg single administration) were administered by dividing the rats into the following five groups: TP 1 μg group {T(1): TP 1 μg/kg}, ZA group (ZA:0.1 mg/kg), TP1 μg+ZA group {T(1)+ZA: TP 1 μg/kg+ZA}, TP 10 μg+ZA group {T(10)+ZA: TP 10 μg/kg + ZA}, and control group (C: administered saline). Rt femurs were excised 7 weeks after the surgery; bone fusions were evaluated with soft X-ray images on a 4-point scale. And the histopathological examination was performed in demineralized and non-demineralized specimens. Furthermore, the Radiographic Union Scale was conducted in all specimens. RESULTS: About the bone fusions rates, C, T(1), ZA, T(1)+ZA, and T(10)+ZA groups demonstrated 20.0%, 55.6%, 70.0%, 70.0%, and 80.0%, respectively, and with 4-point scale, each group was 0.50, 1.56, 2.00, 2.60, and 2.80 points, respectively. The callus volume was significantly increased to 16.66 mm(2) and 17.75 mm(2) in the T(1)+ZA and T(10)+ZA groups, respectively, while 10.65 mm(2) (p < 0.05) in the C group. Furthermore, the callus area in the T(10)+ZA group was also observed to have significantly increased to 78.78%, compared with 54.63% and 44.11% in the C and T(1)+ZA groups, respectively (p < 0.01). Histopathologically, cartilage tissue and immature callus formation were observed at the bone junction in the C group; however, the osseous bridge formation of mature callus was observed in the ZA, T(1)+ZA, and T(10)+ZA groups. CONCLUSION: It is suggested that administration of low dose TP and ZA in combination may lead to the treatment of delayed union of fracture. We hope the combination treatment may become one of new therapeutic strategy.
format Online
Article
Text
id pubmed-6202815
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62028152018-11-01 Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model Tsubouchi, Yuta Ikeda, Shinichi Kataoka, Masashi Tsumura, Hiroshi J Orthop Surg Res Research Article BACKGROUND: Delay in fracture healing or non-union can be devastating complication. Recent studies have reported that teriparatide (TP) demonstrated effectively on callus formation and mechanical strength and zoledronate (ZA) increased the callus size and resistance at the fracture site in rat fracture model. In this study, the effects of combination therapy with low dose TP and ZA on fracture healing was evaluated. METHODS: From 1 week post-operation, TP (5 times a week administration) and ZA (0.1 mg/kg single administration) were administered by dividing the rats into the following five groups: TP 1 μg group {T(1): TP 1 μg/kg}, ZA group (ZA:0.1 mg/kg), TP1 μg+ZA group {T(1)+ZA: TP 1 μg/kg+ZA}, TP 10 μg+ZA group {T(10)+ZA: TP 10 μg/kg + ZA}, and control group (C: administered saline). Rt femurs were excised 7 weeks after the surgery; bone fusions were evaluated with soft X-ray images on a 4-point scale. And the histopathological examination was performed in demineralized and non-demineralized specimens. Furthermore, the Radiographic Union Scale was conducted in all specimens. RESULTS: About the bone fusions rates, C, T(1), ZA, T(1)+ZA, and T(10)+ZA groups demonstrated 20.0%, 55.6%, 70.0%, 70.0%, and 80.0%, respectively, and with 4-point scale, each group was 0.50, 1.56, 2.00, 2.60, and 2.80 points, respectively. The callus volume was significantly increased to 16.66 mm(2) and 17.75 mm(2) in the T(1)+ZA and T(10)+ZA groups, respectively, while 10.65 mm(2) (p < 0.05) in the C group. Furthermore, the callus area in the T(10)+ZA group was also observed to have significantly increased to 78.78%, compared with 54.63% and 44.11% in the C and T(1)+ZA groups, respectively (p < 0.01). Histopathologically, cartilage tissue and immature callus formation were observed at the bone junction in the C group; however, the osseous bridge formation of mature callus was observed in the ZA, T(1)+ZA, and T(10)+ZA groups. CONCLUSION: It is suggested that administration of low dose TP and ZA in combination may lead to the treatment of delayed union of fracture. We hope the combination treatment may become one of new therapeutic strategy. BioMed Central 2018-10-25 /pmc/articles/PMC6202815/ /pubmed/30359257 http://dx.doi.org/10.1186/s13018-018-0917-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tsubouchi, Yuta
Ikeda, Shinichi
Kataoka, Masashi
Tsumura, Hiroshi
Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model
title Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model
title_full Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model
title_fullStr Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model
title_full_unstemmed Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model
title_short Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model
title_sort combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202815/
https://www.ncbi.nlm.nih.gov/pubmed/30359257
http://dx.doi.org/10.1186/s13018-018-0917-8
work_keys_str_mv AT tsubouchiyuta combinationtherapywithlowdoseteriparatideandzoledronatecontributestofracturehealingonratfemoralfracturemodel
AT ikedashinichi combinationtherapywithlowdoseteriparatideandzoledronatecontributestofracturehealingonratfemoralfracturemodel
AT kataokamasashi combinationtherapywithlowdoseteriparatideandzoledronatecontributestofracturehealingonratfemoralfracturemodel
AT tsumurahiroshi combinationtherapywithlowdoseteriparatideandzoledronatecontributestofracturehealingonratfemoralfracturemodel